Bausch Health Companies Inc.BHCNYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.7%
5Y CAGR+8.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+11.7%/yr
vs +4.6%/yr prior
5Y CAGR
+8.8%/yr
Consistent
Acceleration
+7.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $739.00M | +16.6% |
| 2024 | $634.00M | +5.0% |
| 2023 | $604.00M | +14.0% |
| 2022 | $530.00M | +12.1% |
| 2021 | $473.00M | -2.5% |
| 2020 | $485.00M | -6.0% |
| 2019 | $516.00M | +16.7% |
| 2018 | $442.00M | +19.8% |
| 2017 | $369.00M | -21.3% |
| 2016 | $469.00M | - |